Andrzej Jakubowiak to Protein Kinase Inhibitors
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Protein Kinase Inhibitors.
Connection Strength
0.629
-
Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models. Cancer Med. 2020 01; 9(1):324-334.
Score: 0.525
-
Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells. Blood Cancer J. 2016 08 19; 6(8):e460.
Score: 0.105